More on SLNO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Soleno Therapeutics (NQ:SLNO)
Delayed: 39.68 +1.11 (2.88%)
Prev. Close $38.57  
Open$38.09 
52 Wk High$ 
52 Wk Low$ 
Day High$39.74 
Day Low$37.50 
P/E N/A  
EPS$ 
Volume1,756,260 

Friends, Peers and Foes (?): ACAD, VRNA, BBIO, CRNX, CYTK (more...)

Mar 4, 2026 06:00 PM Form 4 SOLENO THERAPEUTICS INC For: Mar 02 Filed by: Fulk Jennifer
Mar 4, 2026 05:58 PM Form 3 SOLENO THERAPEUTICS INC For: Mar 02 Filed by: Fulk Jennifer
Mar 4, 2026 06:41 AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $100 at H.C. Wainwright
Feb 27, 2026 06:56 AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $110 at Wells Fargo
Feb 26, 2026 10:24 AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $85 at TD Cowen
Feb 26, 2026 08:02 AM Soleno Therapeutics names Jennifer Fulk as CFO, James Mackaness to retire
Feb 26, 2026 08:01 AM Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
Feb 26, 2026 06:12 AM Form 8-K SOLENO THERAPEUTICS INC For: Feb 25
Feb 25, 2026 04:59 PM Form S-8 SOLENO THERAPEUTICS INC
Feb 25, 2026 04:35 PM Form 10-K SOLENO THERAPEUTICS INC For: Dec 31
View All Articles

Entities mentioned with SLNO

View All Entities